- Home
- ICUI vs CGAU Comparison
ICUI vs CGAU Comparison
Compare ICUI & CGAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICUI | CGAU |
|---|---|---|
| Founded | 1984 | 2002 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.9B |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ICUI | CGAU |
|---|---|---|
| Price | $114.90 | $17.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $169.00 | $16.67 |
| AVG Volume (30 Days) | 217.1K | ★ 1.4M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.12% |
| EPS Growth | ★ 100.62 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $2,231,262,000.00 | N/A |
| Revenue This Year | N/A | $25.17 |
| Revenue Next Year | $4.46 | $13.62 |
| P/E Ratio | $4,033.00 | ★ $11.74 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $107.02 | $6.31 |
| 52 Week High | $160.29 | $21.17 |
Technical Indicators
Market Signals| Indicator | ICUI | CGAU |
|---|---|---|
| Relative Strength Index (RSI) | 30.63 | 40.99 |
| Support Level | $114.51 | $16.43 |
| Resistance Level | $133.16 | $20.18 |
| Average True Range (ATR) | 4.39 | 0.70 |
| MACD | -0.57 | -0.19 |
| Stochastic Oscillator | 8.31 | 0.36 |
Price Performance
Historical ComparisonAbout ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
About CGAU Centerra Gold Inc.
Centerra Gold Inc is principally focused on operating, developing, exploring and acquiring gold and copper properties in North America, Turkey, and other markets world-wide. The company reportable operating segments are Oksut; Mount Milligan; and Molybdenum. It derives maximum revenue from Mount Milligan segment. Geographically, it operates in Turkey, United States, and Canada.